Evidence mapPaperPMID 41150994Full record

ArticleDiabetes2026

Microvascular Homeostasis Is Compromised in Pancreatic Islets in a Mouse Model of β-Cell Loss and Low-Grade Inflammation.

Luciana Mateus Gonçalves, Isha Shirvaikar, Konstandina Sideris, Elizabeth Pereira, Marjan Slak Rupnik, Joana Almaça

Abstract read
In one paragraph

Article in Diabetes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Luciana Mateus GonçalvesDivision of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL.
Isha ShirvaikarDivision of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL.
Konstandina SiderisDivision of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL.
Elizabeth PereiraDivision of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL.
Marjan Slak RupnikCenter for Physiology and Pharmacology, Comprehensive Center for AI in Medicine, Medical University of Vienna, Vienna, Austria.
Joana AlmaçaDivision of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL.ORCID 0000-0002-9316-712X

Funding

Integrative analysis of multi-omic signatures and cellular function in human pancreas across developmental timeline at single-cell spatial resolutionU01DK135017 · VANDERBILT UNIVERSITY MEDICAL CENTER · 2025 to 2025
$800k
Loss of insulin signaling across functional pancreas compartments as a major pathogenic mechanism underlying diabetic exocrine pancreatopathyR01DK138471 · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · 2025 to 2025
$664k
Investigating the link between pericyte dysfunction and loss of glucose homeostasis in COVID-19R01DK133483 · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · 2025 to 2025
$384k
Breakthrough T1D 3-PDF-2024-1503-A-NNIDDK NIH HHS R01 DK133483NIDDK NIH HHS R01 DK138471NIDDK NIH HHS U01 DK135017NIH HHS R01DK133483NIH HHS R01DK138471NIH HHS U01DK135017Vienna Science and Technology Fund LS23-026
6 · The paper itself

Abstract

Vascular dysfunction is considered a consequence of diabetes. However, in pancreatic islets, some hemodynamic changes occur before the onset of symptoms. The underlying mechanisms driving islet vascular abnormalities have not been fully characterized, but islet pericyte dysfunction seems to be an early event in the pathogenesis of type 1 diabetes in humans. It remains to be investigated, however, how abnormal pericyte physiology affects their ability to regulate islet blood flow and vascular permeability. To address this issue, we treated mice with multiple subdiabetogenic doses of the β-cell toxin streptozotocin (STZ; 50 mg/kg) and recorded islet vascular responses when animals developed glucose intolerance but were still not diabetic (average fed glycemia <200 mg/dL). At this stage, pericyte coverage of islet capillaries was abnormal, with capillaries either lacking pericytes or being covered by dysfunctional mural cells, which compromised islet vasomotor responses recorded ex vivo in living pancreas slices. These functional defects interfered with proper regulation of blood flow and compromised islet vascular integrity, because large fluorescent dextrans (500 kDa) could leak from peripheral islet vessels in the exteriorized pancreas of STZ-treated mice. Our study supports that the loss of functional pericyte coverage of islet capillaries is part of a pathogenic process occurring in islets before diabetes onset, associated with a loss of functional β-cell mass and inflammation. ARTICLE HIGHLIGHTS: Pericyte dysfunction is an early event in type 1 diabetes in humans, but how it affects islet microvascular homeostasis in vivo is unknown. We sought to determine whether vascular integrity and blood flow regulation in islets were impaired in a model of partial β-cell loss and inflammation. Islet capillaries lost functional pericyte coverage shortly after low-dose streptozotocin, compromising vascular stability and local control of blood flow. Strategies that preserve vascular niches in islets could be of important therapeutic potential.

Indexed as

Diabetes Mellitus, ExperimentalInflammationInsulin-Secreting CellsIslets of LangerhansAnimalsCapillary PermeabilityDiabetes Mellitus, Type 1HomeostasisMaleMiceMice, Inbred C57BLPericytes

Identifiers

PMID41150994
PMCPMC12716606

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.